A low von Willebrand factor antigen test means the blood sample contains less von Willebrand factor protein than expected. Von Willebrand factor, often shortened to vWF or VWF, helps platelets stick to an injured blood vessel and carries factor VIII, another clotting protein, through the bloodstream. When the antigen level is low, the body has less of this protein available, which raises the chance of nosebleeds, easy bruising, heavy menstrual bleeding, prolonged bleeding after dental work, or bleeding after surgery.
A low result does not always mean severe disease. Some people have mildly low vWF because of blood type O, normal biologic variation, age, thyroid disease, certain heart or blood conditions, or an inherited bleeding disorder such as von Willebrand disease. The result matters most when it matches a personal or family history of bleeding and when vWF activity and factor VIII levels are also abnormal.
- Low vWF antigen usually means the amount of von Willebrand factor protein is below the lab’s reference range, often below about 50 IU/dL or 50%.
- vWF antigen measures quantity, not function; vWF activity shows how well the protein works.
- Levels below 30 IU/dL strongly support type 1 von Willebrand disease when the clinical picture fits.
- Levels from 30–50 IU/dL sit in a gray zone where bleeding history, repeat testing, and related tests guide interpretation.
- Blood type O, recent illness, pregnancy, stress, exercise, inflammation, and estrogen exposure affect vWF levels.
- Urgent care is needed for heavy uncontrolled bleeding, black stools, vomiting blood, severe headache after trauma, or bleeding during pregnancy.
Table of Contents
- What a Low vWF Antigen Result Means
- Normal, Low, and Borderline Ranges
- Common Causes of Low vWF Antigen
- Bleeding Risk and Symptoms
- Follow-Up Tests and Diagnosis
- What Affects Test Accuracy
- Treatment and Bleeding Prevention
- When to Contact a Clinician
What a Low vWF Antigen Result Means
A low vWF antigen result means the blood contains a reduced amount of von Willebrand factor protein. The test is called “antigen” because it measures how much protein is present, not how well that protein works.
Von Willebrand factor has two main jobs in normal clotting. First, it helps platelets attach to damaged blood vessel walls, especially in small vessels where bleeding from the skin, nose, gums, uterus, and digestive tract occurs. Second, it protects factor VIII from being cleared too quickly from the blood. When vWF antigen is low, factor VIII also often drops, which sometimes lengthens the aPTT blood clotting test.
A low antigen result answers one question: “How much vWF protein is in the blood?” It does not fully answer these questions:
- Does the vWF work normally?
- Is the low level inherited or acquired?
- Is the person at meaningful bleeding risk?
- Does the person meet criteria for von Willebrand disease?
- Is treatment needed before surgery, childbirth, dental extraction, or another procedure?
That is why clinicians rarely interpret vWF antigen by itself. They compare it with vWF activity, factor VIII activity, bleeding history, family history, medications, blood type, and repeat test results.
The most common pattern with low vWF antigen is a quantitative problem. The body either makes too little vWF, releases too little into the bloodstream, or clears it too quickly. This pattern appears in type 1 von Willebrand disease, low vWF, and several acquired conditions.
Low vWF antigen differs from low vWF activity. Antigen is the amount of protein. Activity is how well the protein helps platelets bind. A person with low antigen usually has low activity because there is less protein available. A person with normal antigen but low activity has a functional problem, which points more toward type 2 von Willebrand disease. The vWF activity test helps separate these patterns.
The result also needs clinical context. A mildly low value in someone with no bleeding symptoms, no family history, and blood type O does not carry the same meaning as the same value in someone with lifelong nosebleeds, heavy periods, postpartum bleeding, and bleeding after dental work.
Normal, Low, and Borderline Ranges
Most laboratories report vWF antigen as IU/dL or as a percentage. In practical terms, 50 IU/dL is usually similar to 50%. Some reports use IU/mL, where 0.50 IU/mL equals 50 IU/dL.
A typical adult reference range is about 50–200 IU/dL, but each laboratory sets its own range based on its method and population. The lab’s printed reference interval should be used first.
| vWF antigen result | Common interpretation | What it usually means in practice |
|---|---|---|
| About 50–200 IU/dL | Typical reference range in many labs | Usually enough vWF protein, though activity testing is still needed when bleeding symptoms are strong |
| 30–50 IU/dL | Low or borderline-low range | Often called low vWF; diagnosis depends on bleeding history, repeat testing, activity, and factor VIII |
| Below 30 IU/dL | Clearly low | Strongly supports type 1 von Willebrand disease when inherited bleeding symptoms fit |
| Very low or undetectable | Severe deficiency pattern | Raises concern for severe von Willebrand disease, especially type 3, when activity and factor VIII are also very low |
The 30 IU/dL and 50 IU/dL cutoffs matter because vWF levels form a spectrum. People below 30 IU/dL more often have identifiable changes in the VWF gene and a clearer inherited disorder. People between 30 and 50 IU/dL often have a mixed picture. Some have clinically important bleeding and are diagnosed with type 1 von Willebrand disease under modern guidelines. Others have low levels with little or no bleeding.
This gray zone explains why the label alone does not predict bleeding. A value of 42 IU/dL in a person with severe lifelong bleeding deserves more attention than 42 IU/dL found during a screening panel in a person with no bleeding problems.
The vWF antigen normal range also changes with age and physiologic state. vWF often rises as people get older. It also rises during pregnancy, inflammation, acute infection, intense exercise, surgery, trauma, and stress. Because vWF is an acute-phase reactant, a normal result during illness does not always rule out a lower baseline level.
Results below the reference range deserve repeat testing when the clinical question is not urgent. Repeating the panel when the person is well, not pregnant, and not recovering from a recent inflammatory illness gives a more reliable baseline.
Common Causes of Low vWF Antigen
Low vWF antigen has inherited and acquired causes. Some causes create a lifelong pattern. Others develop later because another condition changes vWF production, release, binding, or clearance.
Inherited low vWF and type 1 von Willebrand disease
The most important inherited cause is type 1 von Willebrand disease. Type 1 is a partial quantitative deficiency, meaning the person has less vWF than expected but the protein that is present often works reasonably well. vWF activity and factor VIII levels often fall along with antigen.
Type 1 von Willebrand disease usually causes mucocutaneous bleeding. That means bleeding from surfaces such as the nose, mouth, skin, uterus, and gastrointestinal tract. Symptoms often include frequent nosebleeds, easy bruising, prolonged bleeding from cuts, heavy menstrual bleeding, and excess bleeding after dental work, childbirth, or surgery.
A result below 30 IU/dL makes type 1 von Willebrand disease more likely, especially when bleeding symptoms started early in life or relatives have similar symptoms. Results from 30–50 IU/dL need closer judgment. Current diagnostic thinking places more weight on the person’s bleeding phenotype than older approaches that separated “low vWF” from “disease” by a single number.
Blood type O
Blood type O is one of the most common reasons for lower vWF antigen. People with type O blood, on average, have lower vWF levels than people with non-O blood types. This does not mean blood type O is a bleeding disorder. It means a mildly low vWF antigen result is more common in this group.
Blood type explains part of the variation between healthy people, but it should not be used to dismiss real bleeding symptoms. A person with blood type O and heavy surgical bleeding still needs a proper bleeding evaluation.
Acquired von Willebrand syndrome
Acquired von Willebrand syndrome means vWF becomes low or dysfunctional because of another medical condition rather than an inherited VWF gene problem. It often appears later in life and has no childhood bleeding history.
Causes include:
- Aortic stenosis and some other heart valve or mechanical circulation problems
- Left ventricular assist devices and other high-shear blood flow states
- Certain blood cancers or monoclonal gammopathies
- Autoimmune conditions with antibodies that remove or interfere with vWF
- Hypothyroidism
- Some medications or cancer therapies
Acquired forms matter because treating the underlying condition often improves the vWF problem. For example, correcting severe aortic stenosis sometimes improves acquired vWF abnormalities.
Hypothyroidism
Low thyroid hormone levels reduce several clotting proteins in some people, including vWF. Hypothyroidism-related low vWF antigen usually improves after thyroid hormone levels are corrected. A thyroid-stimulating hormone test is often reasonable when low vWF appears with fatigue, cold intolerance, constipation, dry skin, weight gain, slow heart rate, or menstrual changes.
Increased clearance of vWF
Some people clear vWF from the bloodstream faster than expected. Their bodies produce vWF, but the protein does not stay in circulation long enough. This pattern is sometimes investigated with the vWF propeptide-to-antigen ratio, specialized multimer testing, or genetic testing. Faster clearance affects treatment choices because desmopressin might raise levels at first but the effect fades sooner than expected.
Severe type 3 von Willebrand disease
Type 3 von Willebrand disease is rare and severe. vWF antigen is extremely low or undetectable, vWF activity is extremely low, and factor VIII is often low enough to cause deep tissue bleeding patterns that resemble hemophilia. People with type 3 disease often have major bleeding from early life and need specialist care.
Bleeding Risk and Symptoms
Bleeding risk rises when low vWF antigen matches a real bleeding history, low vWF activity, low factor VIII, or a family history of abnormal bleeding. The number matters, but the symptoms matter just as much.
The bleeding pattern of low vWF is usually surface-type bleeding rather than spontaneous deep muscle bleeding. Common symptoms include:
- Nosebleeds lasting longer than 10 minutes or needing medical treatment
- Easy bruising, especially large bruises without clear injury
- Bleeding from the gums outside routine brushing irritation
- Prolonged bleeding after cuts, dental extraction, tonsillectomy, or surgery
- Heavy menstrual bleeding, such as soaking protection hourly, passing large clots, or needing double protection
- Iron deficiency from menstrual or gastrointestinal blood loss
- Excess bleeding after childbirth or miscarriage procedures
- Blood in stool or black stools from gastrointestinal bleeding
Heavy menstrual bleeding is one of the most important clues. People often normalize it because it has been present since adolescence or runs in the family. A low vWF antigen result becomes more meaningful when heavy periods come with iron deficiency, low ferritin, anemia, missed school or work, or prior treatment for excessive bleeding.
Low vWF does not always cause daily symptoms. Many people bleed only when challenged by dental work, surgery, childbirth, trauma, or anticoagulant medication. This is why a person with “mild” low vWF still needs a plan before procedures.
Bleeding scores help clinicians turn a bleeding history into a more consistent assessment. These tools ask about nosebleeds, bruising, mouth bleeding, dental bleeding, surgery, menstruation, postpartum bleeding, muscle bleeding, joint bleeding, and transfusions. A high score supports further evaluation, especially when vWF antigen sits in the 30–50 IU/dL range.
Low vWF antigen also links with factor VIII. Since vWF carries factor VIII, less vWF often means factor VIII drops. Low factor VIII can add to bleeding risk and sometimes prolong aPTT. A related low factor VIII activity result helps clinicians judge whether the clotting problem is limited to vWF or involves a broader factor VIII issue.
The main point is practical: the risk is not determined by the lab value alone. A person with 45 IU/dL and repeated surgical bleeding needs careful planning. A person with 45 IU/dL and no bleeding history still deserves documentation and repeat testing, but the immediate risk is usually lower.
Follow-Up Tests and Diagnosis
A low vWF antigen result usually leads to a von Willebrand disease evaluation rather than a single-test diagnosis. The core panel compares vWF quantity, vWF function, and factor VIII.
The usual follow-up tests include:
- vWF antigen to measure protein amount
- vWF activity to measure platelet-binding function
- Factor VIII activity to assess the clotting protein carried by vWF
- Blood type, because type O lowers expected vWF levels
- CBC and ferritin when heavy bleeding or iron deficiency is suspected
- PT/INR and aPTT to screen broader clotting pathways
- vWF multimer analysis when type 2 disease is possible
- vWF collagen-binding or newer activity assays in selected cases
- Desmopressin challenge testing when treatment planning requires it
- Genetic testing in selected cases, especially type 2, type 3, severe type 1, or unclear family patterns
The von Willebrand disease panel brings the most important first-line pieces together. When antigen and activity are both low in a similar proportion, a quantitative deficiency such as type 1 VWD or low vWF becomes more likely. When activity is much lower than antigen, a qualitative type 2 pattern becomes more likely.
The activity-to-antigen ratio helps separate these patterns. A low ratio suggests the vWF protein is present but not working properly. That finding often leads to multimer testing and subtype evaluation because treatment and medication cautions differ by subtype.
A CBC also matters because platelet count and anemia change the clinical picture. Low platelets cause bleeding through a different mechanism and can worsen bleeding from low vWF. A platelet count test helps identify this separate issue.
Diagnosis depends on combining all of the following:
- Lab pattern
- Personal bleeding history
- Family history
- Repeat results
- Age and physiologic state at testing
- Other conditions that raise or lower vWF
- Medication use
- Procedure or pregnancy history
Repeat testing is common because vWF levels fluctuate. A person tested during a viral illness, inflammatory flare, pregnancy, severe stress, or shortly after surgery might have a falsely reassuring level. A person tested when well gives a truer baseline.
The diagnosis also changes with life stage. vWF tends to rise with age in many people. Some adults with previously low levels later test in the normal range, yet their past bleeding history and procedure risk still matter. A normalized result does not erase a well-documented bleeding phenotype.
What Affects Test Accuracy
vWF antigen is a sensitive test, but the result shifts with biology and timing. A single result should not be treated as a fixed lifetime value.
Several factors raise vWF and can mask a low baseline:
- Pregnancy, especially later pregnancy
- Estrogen-containing therapy in some people
- Acute infection or inflammation
- Recent surgery, trauma, or bleeding
- Intense exercise before the test
- Physical or emotional stress
- Older age
- Obesity
- Smoking and vascular inflammation in some settings
Several factors lower or contribute to low vWF:
- Blood type O
- Inherited quantitative vWF deficiency
- Hypothyroidism
- Certain acquired immune or blood disorders
- High-shear heart valve or circulatory device conditions
- Increased clearance of vWF from the blood
Timing matters most when the result is borderline. A vWF antigen of 52 IU/dL during inflammation might not rule out a baseline of 35–45 IU/dL. A repeat panel when the person is well is often more useful than arguing over a single number.
Specimen handling also matters. Coagulation samples need correct collection into citrate tubes, proper filling of the tube, prompt processing, and appropriate storage. Underfilled tubes, clotted samples, delayed processing, or mishandling can distort clotting test results. When a result conflicts strongly with the clinical story, repeating the test at a lab experienced in coagulation testing is reasonable.
Medications also change interpretation. Aspirin, nonsteroidal anti-inflammatory drugs, antiplatelet medicines, anticoagulants, and some supplements do not necessarily lower vWF antigen, but they increase bleeding risk or affect other tests. A person with low vWF who also takes aspirin or anticoagulants needs individualized procedure planning.
Menstrual timing does not fully explain large vWF differences, but hormonal therapy, pregnancy, postpartum changes, and iron deficiency often matter clinically. For heavy menstrual bleeding, the evaluation should not stop after one normal or borderline test if the history is strong.
Treatment and Bleeding Prevention
Treatment is based on bleeding risk, planned procedures, vWF subtype, vWF activity, factor VIII level, prior response to medication, age, pregnancy status, and other health conditions. Not every person with low vWF antigen needs daily treatment.
The main goal is targeted prevention. Many people need treatment only before surgery, dental extraction, childbirth, or during heavy bleeding episodes.
Common options include:
- Tranexamic acid for mouth bleeding, nosebleeds, heavy menstrual bleeding, and dental procedures
- Desmopressin for selected people whose bodies release enough stored vWF after a test dose
- vWF-containing concentrates for major surgery, severe bleeding, type 3 VWD, poor desmopressin response, or desmopressin-inappropriate situations
- Hormonal options or a levonorgestrel intrauterine system for heavy menstrual bleeding
- Iron testing and iron replacement when chronic bleeding causes low ferritin or anemia
- Treatment of underlying causes in acquired von Willebrand syndrome
Tranexamic acid helps stabilize clots after they form. It is especially useful for mucosal bleeding, including dental work and heavy periods. It does not raise vWF levels, but it reduces clot breakdown at high-fibrinolysis sites such as the mouth and uterus.
Desmopressin prompts the lining of blood vessels to release stored vWF and factor VIII. It works well for many people with type 1 VWD or low vWF, but not for everyone. A supervised desmopressin challenge test shows whether levels rise enough and stay high long enough. Desmopressin is avoided or used with caution in some people, including those with significant heart disease, seizure risk, very young children, certain type 2 patterns, and older adults depending on local practice. It also carries a risk of low sodium, so fluid instructions matter.
vWF concentrate replaces the missing protein directly. It is used when bleeding is serious, surgery is major, desmopressin does not work, desmopressin is unsafe, or the subtype requires replacement. Major surgery often requires repeated dosing and monitoring of both vWF activity and factor VIII.
Procedure planning should happen before the procedure date. The plan often includes the diagnosis, baseline labs, target vWF and factor VIII levels, medication choice, dose timing, repeat lab timing, and whether tranexamic acid should continue afterward. Dental extraction, tonsil surgery, endoscopy with biopsy, childbirth, and major surgery all need different levels of planning.
People with low vWF should tell clinicians before new prescriptions or procedures. Aspirin and NSAIDs such as ibuprofen and naproxen can worsen platelet-related bleeding in some patients. Acetaminophen is often preferred for pain or fever unless another clinician has advised otherwise. Anyone taking anticoagulants or antiplatelet therapy needs coordinated advice rather than stopping medication alone.
When to Contact a Clinician
A low vWF antigen result deserves follow-up with the clinician who ordered the test, especially when bleeding symptoms are present. A hematologist is often helpful when the result is clearly low, repeated, paired with low activity or factor VIII, or relevant to surgery, pregnancy, or childbirth.
Schedule medical follow-up when any of these apply:
- vWF antigen is below the lab reference range on more than one test
- vWF antigen is below 30 IU/dL
- vWF activity or factor VIII is also low
- Nosebleeds are frequent, prolonged, or require packing or cautery
- Periods are heavy enough to cause iron deficiency, anemia, flooding, or missed activities
- Bleeding occurred after dental work, surgery, childbirth, or miscarriage care
- A close relative has von Willebrand disease or unexplained bleeding
- A procedure, pregnancy, or delivery is planned
- Low vWF appeared for the first time later in life, which raises concern for acquired causes
Seek urgent care for bleeding that is heavy, persistent, or in a dangerous location. Warning signs include vomiting blood, black tarry stool, heavy rectal bleeding, severe headache after injury, weakness or fainting with bleeding, large expanding bruises, bleeding that does not slow with pressure, or heavy pregnancy-related bleeding.
Bring useful details to the appointment. The most helpful information includes old surgical records, dental bleeding history, childbirth bleeding history, menstrual bleeding details, transfusion or iron infusion history, family bleeding history, medication and supplement list, and copies of prior coagulation tests. A clear timeline often changes the interpretation of a borderline result.
A low vWF antigen test is not a stand-alone diagnosis, but it is an important clue. When the result is interpreted with bleeding history and a complete vWF panel, it helps identify who needs reassurance, who needs repeat testing, who needs a von Willebrand disease diagnosis, and who needs a specific prevention plan before bleeding risk rises.
References
- ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease 2021 (Guideline)
- ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease 2021 (Guideline)
- von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis 2022 (Systematic Review)
- Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies 2024 (Study)
- Low von Willebrand factor-unraveling an enigma wrapped in a conundrum 2024 (Review)
- 2025 ASH ISTH NBDF WFH monitoring report on the 2021 clinical guidelines on the diagnosis and management of von Willebrand disease 2025 (Monitoring Report)
Disclaimer
This article is educational and does not replace medical care from a qualified clinician. A low vWF antigen result needs interpretation with bleeding history, repeat testing, vWF activity, factor VIII, and the reason the test was ordered. Seek urgent medical care for heavy bleeding, pregnancy-related bleeding, black stools, vomiting blood, or bleeding after an injury that does not stop.
